Safety of enteral naloxone and i.v. neostigmine when used to relieve constipation.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  American Journal of Health-System Pharmacy

• Publication date

  2003-06-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/AJHP/60.12.1264PMID 12845923
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neostigmine resolves critical illness-related colonic ileus in intensive care patients with multiple organ failure – a prospective, double-blind, placebo-controlled trial

  2001cited by this paper
• Opioid Antagonists in the Treatment of Opioid-Induced Constipation and Pruritus

  2001cited by this paper
• Oral naloxone reverses opioid‐associated constipation

  2000cited by this paper
• Neostigmine for the treatment of acute colonic pseudo-obstruction.

  1998cited by this paper
• Treatment of opioid‐induced constipation with oral naloxone: A pilot study

  1992cited by this paper
• Oral naloxone in opioid-associated constipation.

  1991cited by this paper
• Oral naloxone in opioid-associated constipation.

  1991cited by this paper
• Role of opiate receptors in the regulation of colonic transit.

  1988cited by this paper
• Beneficial effects of naloxone in a patient with intestinal pseudoobstruction.

  1985cited by this paper

• Neostigmine for the Treatment of Gastrointestinal Atony: A Report of One Case

  2011cites this paper
• Critically Ill Adult Patients Critical Illness , Gastrointestinal Complications , and Medication Therapy during Enteral Feeding in

  2010cites this paper
• Critical illness, gastrointestinal complications, and medication therapy during enteral feeding in critically ill adult patients.

  2010cites this paper
• Safety of enteral naloxone for the reversal of opiate‐induced constipation in the intensive care unit

  2009cites this paper
• Recommandations pour la prévention et le traitement de la constipation induite par les opioïdes chez le patient relevant de soins palliatifs

  2009cites this paper
• Medication Induced Constipation and Diarrhea

  2008cites this paper
• Potentiation by cholinesterase inhibitors of cholinergic activity in rat isolated stomach and colon.

  2008cites this paper
• Mu-opioid antagonists for opioid-induced bowel dysfunction.

  2008cites this paper
• How to ENHANCE our knowledge of activated protein C during pediatric sepsis trials: pediatric versus adult trials.

  2006cites this paper
• Opioids causing a back up in the pediatric intensive care unit? No solution yet.

  2006cites this paper
• Der Einfluss von enteralem Naloxon auf die Inzidenz von Gastritis und Ösophagitis bei opioidbehandelten Intensivpatienten: Doppelblinde plazebokontrollierte Studie

  2004cites this paper
• [Effect of enteral naloxone on the incidence of gastritis and esophagitis in mechanically ventilated patients].

  2004cites this paper